Anika Therapeutics, Inc.
ANIK
Revenue
30.62M
▲2.80M▲10.06%
3 Months ChangeAssets
190.27M
▲833.00k▲0.4397%
3 Months ChangeLiabilities
46.81M
▲4.17M▲9.79%
3 Months ChangeFree Cash Flow
-2.95M
▼-1.02M▼-52.74%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001193125-26-073401
2026-01-08
Form 8-K
ID: 0001193125-26-007655
2025-11-05
Form 10-Q
ID: 0001171843-25-007032
2025-11-05
Form 8-K
ID: 0001171843-25-007003
2025-07-30
Form 10-Q
ID: 0001171843-25-004826
2025-07-30
Form 8-K
ID: 0001171843-25-004810
2025-07-30
Form 8-K
ID: 0001171843-25-004809
2025-06-24
Form 8-K
ID: 0001171843-25-004062
2025-05-09
Form 10-Q
ID: 0001171843-25-003019
2025-05-09
Form 8-K
ID: 0001171843-25-003005